Celebrating 17 Years of Advancing Biopharma R&D Innovation, Decision Making and Operations

A conference for people at the intersection of science, business & operations…

In an environment of declining revenues and uncertain commercial success, biopharma, device, and R&D companies must continuously optimize their strategy, evaluate their portfolios, improve decision making, reduce risk, and effectively deploy resources. The oncology and immuno-oncology fields face these challenges and more given the shifting paradigms in this disease area. Cambridge Healthtech Institute and the BioPharma Strategy Series present a full week of high-level content, interactive discussions and networking at the 2nd Annual “Strategic and Operational Challenges of Immuno-Oncology Drug Development” (Mon-Tues), a “Decision Analysis & Project Portfolio Management Master Class” (Mon-Tues), 17th Annual “Strategic Resource Management” (Wed-Thurs), and 14th Annual “Portfolio Management” (Thurs-Fri).

Cambridge Healthtech Institute’s annual executive forum brings together R&D executives from the biopharma community to share best practices in project and portfolio management, R&D innovation, decision analysis, forecasting, resource management, and immuno-oncology drug development. Attendees will gain strategic insights and proven tools, methods, and perspectives from a variety of leaders at the intersection of science, business, and operations.

CONFERENCE AT A GLANCE

Final Weeks to Register!


STRATEGIC AND OPERATIONAL CHALLENGES OF ONCOLOGY AND IMMUNO-ONCOLOGY DRUG DEVELOPMENT


October 14-15, 2019



The Bellevue Hotel
Philadelphia, PA

Discounted Room Rate: $245 s/d
Discounted Room Rate Cut-off Date: September 16, 2019

More Information ▶